Eskayef introduces new coronavirus drug to the market
Eskayef, one of the leading pharmaceutical companies of the country, is introducing yet another drug to the market, for the treatment of coronavirus. This combination drug, Paxovir, has been given ...
Interview: Dr. Tahmeed Ahmed
'Promising scientists should be nurtured'
In the coming years icddr,b will place emphasis on working with non communicable diseases (NCD). Efforts will be made to gain a deep understanding of NCD, says Tahmeed Ahmed
Death toll of Sudan anti-coup protests rises to 40: medics
The death toll in Sudan from anti-coup protests since last month's military takeover has risen to at least 40, medics said Saturday after a teenager shot in the head days earlier died
How antibiotics made superbugs
Antibiotic resistance is a natural phenomenon but humans have quickened the process through the widespread use and overuse of the powerful medicines
Molnupiravir to be a game changer: Physicians
The country’s top physicians have termed molnupiravir a 'game changer' as it will fulfill the need of the medicine that physicians were waiting for to treat of the highly contagious disease, ...
Eskayef starts marketing molnupiravir
Eskayef, one of the top pharmaceutical companies of the country, has brought molnupiravir to the Bangladesh market. This is the first approved drug for treatment of coronavirus across the world.
US panel backtracks on daily aspirin advice
Aspirin, used for decades for pain and fever and available without a prescription, was seen as a convenient and cheap option to help those at risk of serious heart problems